Lv71
4980 积分 2020-04-21 加入
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms
4小时前
已完结
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus
9小时前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
4天前
已完结
IgA vasculitis during secukinumab therapy
5天前
已完结
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial
1个月前
已完结
Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial
2个月前
已关闭
Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial
2个月前
已完结
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis
2个月前
已完结
The ASAS-OMERACT core domain set for axial spondyloarthritis
2个月前
已完结
Instrument selection for the ASAS core outcome set for axial spondyloarthritis
2个月前
已完结
皖公网安备34019202002308
